Full Press Release Details
IDEAYA Biosciences Announces Participation in Jefferies London Healthcare Conference and Plans for Investor R D Day.
IDYA
IDEAYA Biosciences Announces Participation in Jefferies London Healthcare Conference and Plans for Investor R D Day
Key Takeaway: IDEAYA Biosciences Announces Participation in Jefferies London Healthcare Conference and Plans for Investor R D Day
Price reaction · baseline $31.98 (2024-11-11 close) · hit after-hours · clean, no other IDYA news in the window
day 0 close · peak
-3.1%
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+47%
120-day peak, hindsight
Typical move
5.2%
average across 6 past catalysts
Cash runway
~42 mo
Minimal dilution risk
Lead asset
IDE892
Phase 1 · NSCLC Adenocarcinoma